Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 54 results.
User Information
Export Records
  1. 1.   NADPH oxidase 1 is highly expressed in human large and small bowel cancers
  2. Lu, Jiamo; Jiang, Guojian; Wu, Yongzhong; Antony, Smitha; Meitzler, Jennifer L; Juhasz, Agnes; Liu, Han; Roy, Krishnendu; Makhlouf, Hala; Chuaqui, Rodrigo; Butcher,Donna; Konaté, Mariam M; Doroshow, James H
  3. PloS one. 2020, May 19; 15(5): e0233208.
  1. 2.   X-linked carriers of chronic granulomatous disease: Illness, lyonization, and stability
  2. Marciano, Beatriz E; Zerbe, Christa S; Falcone, E Liana; Ding, Li; DeRavin, Suk See; Daub, Janine; Kreuzburg, Samantha; Yockey, Lynne; Hunsberger, Sally; Foruraghi, Ladan; Barnhart, Lisa A; Matharu, Kabir; Anderson, Victoria; Darnell, Dirk N; Frein, Cathleen; Fink, Dani; Lau, Karen; Long-Priel, Debra; Gallin, John I; Malech, Harry L; Uzel, Gulbu; Freeman, Alexandra F; Kuhns, Doug; Rosenzweig, Sergio D; Holland, Steven M
  3. Journal of Allergy and Clinical Immunology. 2018, Jan; 141(1): 365-371.
  1. 3.   Isolation and Functional Analysis of Human Neutrophils
  2. Kuhns, D. B.; Long Priel, D. A.; Chu, J.; Zarember, K. A.
  3. Current Protocols in Immunology. 2015, 2-Nov; 111: 7.23.1-16.
  1. 4.   Molecular-Level Examination of Cu2+ Binding Structure for Amyloid Fibrils of 40-Residue Alzheimer's beta by Solid-State NMR Spectroscopy
  2. Parthasarathy, S.; Long, F.; Miller, Y.; Xiao, Y. L.; McElheny, D.; Thurber, K.; Ma, B. Y.; Nussinov, R.; Ishii, Y.
  3. Journal of the American Chemical Society. 2011, Mar; 133(10): 3390-3400.
  1. 5.   The Nitric Oxide Prodrug JS-K Is Effective against Non-Small-Cell Lung Cancer Cells In Vitro and In Vivo: Involvement of Reactive Oxygen Species
  2. Maciag, A. E.; Chakrapani, H.; Saavedra, J. E.; Morris, N. L.; Holland, R. J.; Kosak, K. M.; Shami, P. J.; Anderson, L. M.; Keefer, L. K.
  3. Journal of Pharmacology and Experimental Therapeutics. 2011, Feb; 336(2): 313-320.
  1. 6.   Magnetic resonance imaging of organic contrast agents in mice: capturing the whole-body redox landscape
  2. Davis, R. M.; Matsumoto, S.; Bernardo, M.; Sowers, A.; Matsumoto, K. I.; Krishna, M. C.; Mitchell, J. B.
  3. Free Radical Biology and Medicine. 2011, Feb; 50(3): 459-468.
  1. 7.   Transcriptional up-regulation of SOD1 by CEBPD: A potential target for cisplatin resistant human urothelial carcinoma cells
  2. Hour, T. C.; Lai, Y. L.; Kuan, C. I.; Chou, C. K.; Wang, J. M.; Tu, H. Y.; Hu, H. T.; Lin, C. S.; Wu, W. J.; Pu, Y. S.; Sterneck, E.; Huang, A. M.
  3. Biochemical Pharmacology. 2010, Aug; 80(3): 325-334.
  1. 8.   Brugia malayi Excreted/Secreted Proteins at the Host/Parasite Interface: Stage- and Gender-Specific Proteomic Profiling
  2. Bennuru, S.; Semnani, R.; Meng, Z.; Ribeiro, J.; Veenstra, T. D.; Nutman, T. B.
  3. Plos Neglected Tropical Diseases. 2009 3(4):
  1. 9.   Axonal Mitochondrial Clusters Containing Mutant SOD1 in Transgenic Models of ALS
  2. Sotelo-Silveira, J. R.; Lepanto, P.; Elizondo, V.; Horjales, S.; Palacios, F.; Martinez-Palma, L.; Marin, M.; Beckman, J. S.; Barbeito, L.
  3. Antioxidants & Redox Signaling. 2009 11(7): 1535-1546.
  1. 10.   DNA damage, superoxide, and mutant K-ras in human lung adenocarcinoma cells
  2. Romanowska, M.; Maciag, A.; Smith, A. L.; Fields, J. R.; Fornwald, L. W.; Kikawa, K. D.; Kasprzak, K. S.; Anderson, L. M.
  3. Free Radical Biology and Medicine. 2007, Oct; 43(8): 1145-1155.
  1. 11.   Molecular consequences of SOD2 expression in epigenetically silenced pancreatic carcinoma cell lines
  2. Hurt, E. M.; Thomas, S. B.; Peng, B.; Farrar, W. L.
  3. British Journal of Cancer. 2007, Oct; 97(8): 1116-1123.
  1. 12.   Integrated molecular profiling of SOD2 expression in multiple myeloma
  2. Hurt, E. M.; Thomas, S. B.; Peng, B. J.; Farrar, W. L.
  3. Blood. 2007, May; 109(9): 3953-3962.
  1. 13.   Proline oxidase activates both intrinsic and extrinsic pathways for apoptosis: the role of ROS/superoxides, NFAT and MEK/ERK signaling
  2. Liu, Y.; Borchert, G. L.; Surazynski, A.; Hu, C. A.; Phang, J. M.
  3. Oncogene. 2006, Sep; 25(41): 5640-5647.
  1. 14.   Onset and progression in inherited ALS determined by motor neurons and microglia
  2. Boillee, S.; Yamanaka, K.; Lobsiger, C. S.; Copeland, N. G.; Jenkins, N. A.; Kassiotis, G.; Kollias, G.; Clevel, D. W.
  3. Science. 2006, JUN 2; 312(5778): 1389-1392.
  1. 15.   A glutathione S-transferase pi-activated prodrug causes kinase activation concurrent with S-glutathionylation of proteins
  2. Townsend, D. M.; Findlay, V. J.; Fazilev, F.; Ogle, M.; Fraser, J.; Saavedra, J. E.; Ji, X. H.; Keefer, L. K.; Tew, K. D.
  3. Molecular Pharmacology. 2006, FEB; 69(2): 501-508.
  1. 16.   Proline oxidase, a p53-induced gene, metabolically activates both intrinsic and extrinsic pathways for apoptosis: The role of superoxide radicals, NFAT and MEK/ERK signaling
  2. Liu, Y. M.; Borchert, G.; Surazynski, A.; Hu, C. A. A.; Phang, J. M.
  3. Clinical Cancer Research. 2005, DEC 15; 11(24, Part 2 Suppl. S): 9038S-9038S.
  1. 17.   Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA
  2. Wang, J.; Xu, G. L.; Slunt, H. H.; Gonzales, V.; Coonfield, M.; Fromholt, D.; Copeland, N. G.; Jenkins, N. A.; Borchelt, D. R.
  3. Neurobiology of Disease. 2005, DEC; 20(3): 943-952.
  1. 18.   Albumin stimulates monocyte chemotactic protein-1 expression in rat embryonic mixed brain cells
  2. Calvo, C. F.; Amigou, E.; Tence, M.; Yoshimura, T.; Glowinski, J.
  3. Journal of Neuroscience Research. 2005, JUN 1; 80(5): 707-714.
  1. 19.   p53 translocation to mitochondria precedes its nuclear translocation and targets mitochondrial oxidative defense protein-manganese superoxide dismutase
  2. Zhao, Y. F.; Chaiswing, L.; Velez, J. M.; Batinic-Haberle, I.; Colburn, N. H.; Oberley, T. D.; St Clair, D. K.
  3. Cancer Research. 2005, MAY 1; 65(9): 3745-3750.
  1. 20.   Cadmium-induced malignant transformation in rat liver cells: role of aberrant oncogene expression and minimal role of oxidative stress
  2. Qu, W.; Diwan, B. A.; Reece, J. M.; Bortner, C. D.; Pi, J. B.; Liu, J.; Waalkes, M. P.
  3. International Journal of Cancer. 2005, APR 10; 114(3): 346-355.
  1. 21.   (salen)Mn-III compounds as nonpeptidyl mimics of catalase. Mechanism-based tuning of catalase activity: A theoretical study
  2. Abashkin, Y. G.; Burt, S. K.
  3. Inorganic Chemistry. 2005, MAR 7; 44(5): 1425-1432.
  1. 22.   Anticancer metal compounds in NCI's tumor-screening database: putative mode of action
  2. Huang, R. L.; Wallqvist, A.; Covell, D. G.
  3. Biochemical Pharmacology. 2005 69(7): 1009-1039.
  1. 23.   Mutant K-ras(V12) increases COX-2, peroxides and DNA damage in lung cells
  2. Maciag, A.; Sithanandam, G.; Anderson, L. M.
  3. Carcinogenesis. 2004, NOV; 25(11): 2231-2237.
  1. 24.   Silencing the formylpeptide receptor FPR by short-interfering RNA
  2. Le, Y. Y.; Iribarren, P.; Zhou, Y.; Gong, W. H.; Hu, J. Y.; Zhang, X.; Wang, J. M.
  3. Molecular Pharmacology. 2004, OCT; 66(4): 1022-1028.
  1. 25.   (Salen)Mn(III) compound as a nonpeptidyl mimic of catalase: DFT study of the metal oxidation by a peroxide molecule
  2. Abashkin, Y. G.; Burt, S. K.
  3. Journal of Physical Chemistry B. 2004 108(8): 2708-2711.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel